US FDA Inspection of Lupin's Nagpur Unit-2 injectable manufacturing facility

The US FDA inspected Lupin's Nagpur Unit-2 injectable manufacturing facility from October 17, 2022 to October 29, 2022. The inspection was a Pre-Approval Inspection of the injectable facility. The inspection closed with issuance of a Form-483 with five observations.

We are committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the U.S.

Shares of Lupin Limited was last trading in BSE at Rs. 696.40 as compared to the previous close of Rs. 703.05. The total number of shares traded during the day was 10530 in over 656 trades.

The stock hit an intraday high of Rs. 703.05 and intraday low of 693.65. The net turnover during the day was Rs. 7346422.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 Nagpur Unit2 InjectableManufacturingFacility Form483 5Observations